Shunsuke Iwano supportS clinical development and regulatory filings in Japan by bio-pharma companies, with a strong desire to solve the drug loss issue in Japan.

Began basic research as an assistant professor at the Graduate School of Pharmaceutical Sciences, Hokkaido University. D. (Pharmaceutical Sciences) while conducting research as an assistant professor. After engaging in basic research as a lecturer at the Faculty of Pharmacy, Takasaki University of Health and Welfare, Shunsuke began drug discovery research at Toray Industries, Inc. Shunsuke contributed to the acquisition of several development compounds as a pharmacokinetic researcher.

Shunsuke moved to Novartis Pharma K.K., where he contributed to global early-stage clinical development as a person in charge, making the most of his expertise in pharmacokinetics. Moved to AbbVie G.K. to perform late-stage clinical development. Served as a clinical development representative, project leader, and head of clinical development. Moved to Sanofi K.K. to gain management experience in a global organization. Shunsuke was involved in the development of regulatory strategy for the Asia Pacific region. Shunsuke participated in a global initiative on organizational transformation as a representative of the Asia Pacific region.